Synthesis Pyrano [2,3-c] Pyrazole-based compounds to induce apoptosis by reducing the expression of anti-apoptotic Bcl-2 protein in human breast cancer MCF-7 cells
Authors
Abstract:
Aim: Bcl-2 is a potential target for tumor treatment. The inhibition of the Bcl-2 production is research target of attract in the field of anti-cancer drug development. Recently, the assessment of antitumor activity appeared to be promising for pyrazole derivatives. Therefore, this study was designed to investigate the anti-cancer effects of novel pyrazole derivatives (HN1and HN2.). Material and methods: The newly synthesized substances were screened in vitro against breast adenocarcinoma (MCF-7). The Western-blot analysis was carried out to study signaling pathways of MCF-7 breast cancer cells. The compounds HN1 and HN2 significantly inhibited the proliferation of human breast cancer cells. Resault: The compounds HN1and HN2 inhibited the growth of MCF-7 cells with IC50 values of 7.4 μg/ml and 8.68 μg/ml, respectively. In addition, compounds HN1and HN2 (22.5-50 μg/ml) significantly inhibited the anti-apoptotic Bcl-2 protein production. The compound HN2 significantly inhibited Bcl-2 expression in a concentration-dependent manner, corresponding 24% at 37.5 μg/ml, 30% at 50 μg/ml. Also compound HN1 at the same concentrations inhibited Bcl-2 expression by 12%, 0% at 37.5 and 50 μg/ml in MCF-7 cells, respectively. Conclusion: HN2 could suppress the viability of MCF-7 cells and induce apoptosis in breast cancer cells by down-regulation of anti-apoptotic factor, Bcl-2.
similar resources
Change in the Expression of BAK، FAS، BAX، TNF-A، BCL-2 and Survivin Apoptosis Genes of the Human Breast Adenocarcinoma Cells (MCF-7) by Staphylococcal Enterotoxin B
Introduction: Breast cancer is one of the most prevalent malignancies among women. Patients whose suffering from this condition, as a result of the use of conventional therapies often have a poor response to treatment and the relapse among them is frequent. In this study, the effects of staphylococcal enterotoxin type B on BAK، FAS، BAX، TNF-a، BCL-2 و Survivin genes expression in human breast ...
full textExpression and anti-apoptotic function of TRAF4 in human breast cancer MCF-7 cells
Tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4) was initially identified as a gene amplified and overexpressed in breast carcinoma. The present study investigated the expression and anti-apoptotic function of TRAF4 in human breast cancer MCF-7 cells. TRAF4 was found to be localized in the cytoplasm and nuclei of MCF-7 cells by immunofluorescence staining and western blotting. T...
full textEffect of rosemary essential oil on the expression of BCL-XL, an anti-apoptotic gene, in MCF-7 cell line breast cancer
full text
Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
Overexpression of HER2 in estrogen receptor (ER)-positive human breast tumors has been associated with resistance to endocrine therapy. Here we investigated the effects of HER2 on expression of apoptotic pathways and modulation of tamoxifen-induced apoptosis in ER-positive MCF-7 breast cancer cells. We report that HER2 overexpression in MCF-7 cells is accompanied by up-regulation of antiapoptot...
full textEffects of combined 5-Fluorouracil and ZnO NPs on human breast cancer MCF-7 Cells: P53 gene expression, Bcl-2 signaling pathway, and invasion activity
Objective(s): The significant contribution of nanoparticles to cancer treatment has attracted therapeutic attention. The present study aimed to evaluate the synergistic effects of 5-fluorouracil (5-FU) and zinc oxide nanoparticles (ZnO NPs) as multimodal drug delivery on human breast cancer MCF-7 cells.Materials and Methods: In this in-vitro study, the impact of 5-FU and ZnO NPs in the sin...
full textStimulatory Effect of Indolic Hormone on As2O3 Cytotoxicity in Breast Cancer Cells: NF-κB-dependent Mechanism of Action of Melatonin
The advent of combination therapy unprecedentedly shifted the paradigm of cancer treatment by reconstructing the conventional protocols. By identifying the anti-tumoral activity for different natural products, recent interest has focused on inventing the combined-modality strategies in order to increase the cure rates of cancer, while reducing the toxic side effects of current intensive regimen...
full textMy Resources
Journal title
volume 25 issue 1
pages 0- 0
publication date 2020-02
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023